Vagal nerve stimulation (VNS) treats treatment-resistant depression with unique benefits: effects improve over 12-24 months, low relapse rates, and reduces ketamine frequency. Learn patient selection criteria, Medicare RECOVER trial access at 80+ sites, insurance appeals process, and how VNS creates a clinical "floor" preventing deepest episodes. Expert insights from Dr. Lucian Manu, Stony Brook University.